z-logo
Premium
Naldemedine for the treatment of opioid‐induced constipation
Author(s) -
Chaplin Steve
Publication year - 2021
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1913
Subject(s) - medicine , constipation , opioid , receptor
Naldemedine (Rizmoic) is a peripherally‐acting mu‐opioid receptor antagonist for the treatment of opioid‐induced constipation in adults. This article outlines its indications, efficacy and adverse effects.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here